SpectraCell Blog

Webinar: Using Advanced Diagnostic Tools for Cardiovascular Health

Posted by SpectraCell Laboratories, Inc. on Wed, Feb 16, 2011 @ 03:53 PM

Cardiovascular WebinarRegister for a seat to February 17's webinar on "Using Advanced Diagnostic Tools for Cardiovascular Health"

Topics Discussed:

- Using advanced lipid testing for better cardiovascular risk assessment
- How the HS-Omega-3 Index® and ApoE Genotyping can better target your treatment strategies
- How to easily implement SpectraCell's LPP™ into your practice
- A busy physician’s guide to rapid report interpretation
- Case study review

 

If this event has passed, please view our WEBINAR LIBRARY for the recorded version of this webinar and many others.

Topics: SpectraCell, lipoprotein particle profile, ApoE Genotyping, HS-Omega-3 Index, LPP, Cholesterol, Omega 3 Fatty Acid, Cardiovascular Health

SpectraCell Receives Patent on its LPP™ Cardiovascular Test

Posted by SpectraCell Laboratories, Inc. on Fri, Jan 28, 2011 @ 01:59 PM

Lipoprotein Particle Profile TestingHouston, TX- January 28, 2011. SpectraCell Laboratories has recently been awarded a patent on their Lipoprotein Particle Profile™ (LPP™) test which is used to measure cardiovascular risk. The LPP™ has been commercially available since 2006, and is a type of advanced cholesterol test that measures lipoprotein subgroups. The LPP™ gives more accurate estimation of cardiovascular risk compared to a routine cholesterol test.

The patent was awarded for use of a “Method for Analyzing Blood for Lipoprotein Components.” Specifically, the LPP™ test utilizes a patented analytical ultracentrifugation method for separating lipoprotein subclasses. This separation method for LPP™ originated at Texas A & M University and was further developed by Dr. Jan Troup, the inventor of LPP™ technology, who is also a member of SpectraCell's scientific staff.

“The LPP™ generally doesn’t cost the patient any more than a standard cholesterol test, but it gives the doctor much more relevant and accurate information.” states Dr. Jan Troup, PhD, and Director of Lipid Science for SpectraCell Laboratories. “Different lipoproteins respond differently to therapy, whether it is statins, fish oils or niacin, for example. The LPP™ enables the doctor to treat appropriately.”

In recent years, the medical community has discovered that, beyond “standard” cholesterol tests, an independent factor for heart disease can be determined by measuring the density and number of lipoprotein particles, to which cholesterol is attached. Patients with a normal cholesterol value, but abnormal particle sizes or numbers, can be at serious risk for cardiovascular disease.

In fact, The National Cholesterol Education Program (NCEP) acknowledges that 50% of people that have heart attacks have “normal” cholesterol – that is, cholesterol below 200 mg/dL. NCEP recognizes four risk factors that are not measured with routine cholesterol testing but are all measured by the LPP™ test:

1. RLP – (remnant lipoprotein) more easily converted into arterial plaque than other lipoproteins

2. Lp(a) – a dangerous lipoprotein that contributes to clot formation

3. HDL2b – a type of HDL that indicates how well cholesterol is being cleared from your system

4. Small, dense LDL – easily penetrates vascular wall, causing damage and plaque

The main reason to know NCEP risk factors are that specific lipoproteins respond to specific therapies very differently. The LPP™ is part of the trend toward more individualized medicine. The LPP™ test, which is done on a fasting blood sample, is usually covered by insurance. Results typically take 3-5 days.

For more information, go to www.spectracell.com

OR

contact Dr. Jan Troup, PhD – Director of Lipid Science  at 800-227-5227

Dr. Jan Troup, Ph.D.

Topics: SpectraCell, lipoprotein particle profile, LPP, Cholesterol, Cardiovascular Health, diagnostic tools, Heart Disease, Lp(a), Lipoprotein Particles, NCEP, RLP, LDL and HDL, Patent, Dr. Jan Troup

SpectraCell's 2011 Educational Webinar Series

Posted by SpectraCell Laboratories, Inc. on Fri, Jan 21, 2011 @ 12:23 PM

2011 Webinar SeriesJoin SpectraCell's 2011 Educational Webinar Series Every 3rd Thursday of the Month

Topics:

  • February 17th - Using Advanced Diagnostic Tools for Cardiovascular Health by Peggy Watson, M.D.   REGISTER HERE...
  • March 17th - Case Study Review: Treating Your Most Common Patient Complaints by Ron Grabowski, R.D., D.C.   REGISTER HERE...
  • April 21st - Using Advanced Diagnostic Testing in a Concierge Practice by Shelena C. Lalji, M.D.   REGISTER HERE...
  • May 19th - Nutritional Considerations of Hormone Balance by Ron Grabowski, R.D., D.C.   REGISTER HERE...
  • June 16th - Clinical Implications of Vitamin D and Calcium Deficiencies by Ron Grabowski, R.D., D.C.   REGISTER HERE...

Time:

8pm eastern - 7pm central - 6pm mountain - 5pm pacific

REGISTER TODAY!

www.SpectraCell.com/Webinars

Topics: SpectraCell, micronutrient testing, Vitamin D, Cardiovascular Health, diagnostic tools, Calcium, deficiencies, Case Study, Hormones, Concierge Practice